Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Starton Therapeutics, Inc

Clinical trials sponsored by Starton Therapeutics, Inc, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Could a Slow-Drip drug tame multiple myeloma with fewer side effects? Results expected May 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Could a Slow-Drip drug tame multiple myeloma with fewer side effects?

Disease control Recruiting now

This trial is testing whether giving lenalidomide as a continuous low-dose infusion under the skin, instead of as a pill, can treat multiple myeloma more safely and effectively. The study includes adults with multiple myeloma who are not eligible for a stem cell transplant. Parti…

Phase 1/2 • Sponsor: Starton Therapeutics, Inc • Aim: Disease control

Last updated Aug 26, 2026 00:00 UTC